MX369169B - Formulaciones de lubricante. - Google Patents

Formulaciones de lubricante.

Info

Publication number
MX369169B
MX369169B MX2016013744A MX2016013744A MX369169B MX 369169 B MX369169 B MX 369169B MX 2016013744 A MX2016013744 A MX 2016013744A MX 2016013744 A MX2016013744 A MX 2016013744A MX 369169 B MX369169 B MX 369169B
Authority
MX
Mexico
Prior art keywords
lubricant formulations
composition
disclosed
lubricant
formulations
Prior art date
Application number
MX2016013744A
Other languages
English (en)
Other versions
MX2016013744A (es
Inventor
richards Kurt
Hoover Andrew
Original Assignee
Reoxcyn LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reoxcyn LLC filed Critical Reoxcyn LLC
Publication of MX2016013744A publication Critical patent/MX2016013744A/es
Publication of MX369169B publication Critical patent/MX369169B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M129/00—Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing oxygen
    • C10M129/02—Lubricating compositions characterised by the additive being an organic non-macromolecular compound containing oxygen having a carbon chain of less than 30 atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/12—Magnesium silicate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/24—Phosphorous; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
    • A61K8/89—Polysiloxanes
    • A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/10—Materials for lubricating medical devices
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10M—LUBRICATING COMPOSITIONS; USE OF CHEMICAL SUBSTANCES EITHER ALONE OR AS LUBRICATING INGREDIENTS IN A LUBRICATING COMPOSITION
    • C10M2229/00—Organic macromolecular compounds containing atoms of elements not provided for in groups C10M2205/00, C10M2209/00, C10M2213/00, C10M2217/00, C10M2221/00 or C10M2225/00 as ingredients in lubricant compositions
    • C10M2229/02—Unspecified siloxanes; Silicones
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10N—INDEXING SCHEME ASSOCIATED WITH SUBCLASS C10M RELATING TO LUBRICATING COMPOSITIONS
    • C10N2030/00—Specified physical or chemical properties which is improved by the additive characterising the lubricating composition, e.g. multifunctional additives
    • C10N2030/04—Detergent property or dispersant property
    • C—CHEMISTRY; METALLURGY
    • C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
    • C10N—INDEXING SCHEME ASSOCIATED WITH SUBCLASS C10M RELATING TO LUBRICATING COMPOSITIONS
    • C10N2030/00—Specified physical or chemical properties which is improved by the additive characterising the lubricating composition, e.g. multifunctional additives
    • C10N2030/16—Antiseptic; (micro) biocidal or bactericidal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Lubricants (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Se divulga una composición para formulaciones de lubricantes. La composición puede incluir hipoclorito, dimeticona y un emulsionante para mejorar la lubricidad. También se divulgan métodos para hacer y utilizar las formulaciones de lubricante.
MX2016013744A 2016-05-18 2016-10-19 Formulaciones de lubricante. MX369169B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15/158,442 US9474768B1 (en) 2016-05-18 2016-05-18 Lubricant formulations

Publications (2)

Publication Number Publication Date
MX2016013744A MX2016013744A (es) 2017-11-17
MX369169B true MX369169B (es) 2019-10-30

Family

ID=57136571

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016013744A MX369169B (es) 2016-05-18 2016-10-19 Formulaciones de lubricante.

Country Status (11)

Country Link
US (4) US9474768B1 (es)
JP (2) JP6464406B2 (es)
KR (1) KR102649938B1 (es)
CN (1) CN107397757A (es)
BR (1) BR102017003973A2 (es)
MX (1) MX369169B (es)
NZ (2) NZ738113A (es)
RU (1) RU2747029C2 (es)
TW (2) TWI674098B (es)
WO (1) WO2017200565A1 (es)
ZA (1) ZA201607310B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150099010A1 (en) 2013-10-07 2015-04-09 Reoxcyn Discoveries Group, Inc Redox signaling gel formulation
WO2017127452A1 (en) 2016-01-19 2017-07-27 Reoxcyn Discoveries Group, Inc. Hypochlorite formulations for wound healing
US11857674B2 (en) 2016-05-18 2024-01-02 Reoxcyn, Llc Lubricant formulations
US9474768B1 (en) * 2016-05-18 2016-10-25 Reoxcyn Discoveries Group, Inc. Lubricant formulations
US9833471B1 (en) 2016-09-15 2017-12-05 Reoxcyn Discoveries Group, Inc. Hypochlorous acid-based hand sanitizer
US20180200165A1 (en) 2017-01-16 2018-07-19 Reoxcyn Innovation Group, Llc Dentifrice formulations and methods of oral care
US10412968B2 (en) 2017-06-28 2019-09-17 Collidion, Inc. Compositions, methods and uses for cleaning, disinfecting and/or sterilizing
US20190099336A1 (en) * 2017-10-03 2019-04-04 Collidion, Inc. Compositions, Methods and Uses for Improving a Skin or Hair Region
US10828325B2 (en) * 2017-12-22 2020-11-10 Reoxcyn, Llc Hypochlorite compositions for the treatment of traumatic brain injury
US10292911B1 (en) * 2017-12-22 2019-05-21 Reoxcyn, Llc Stable redox compositions and methods of use
JP6584588B2 (ja) * 2017-12-22 2019-10-02 レオキシン・エルエルシー セルライトの治療のための組成物及び方法
KR20200123421A (ko) 2018-01-14 2020-10-29 콜리디온, 인코포레이티드 세척, 소독, 멸균 및/또는 치료를 위한 조성물, 키트, 방법 및 용도
US10918663B2 (en) * 2018-04-03 2021-02-16 Reoxcyn, Llc Compositions and methods for the treatment of bacterial vaginosis
US11602582B2 (en) * 2018-04-10 2023-03-14 Chemsil Silicones, Inc. Intimate care lubricant compositions and methods for making same

Family Cites Families (77)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1200165A (en) 1913-10-30 1916-10-03 Charles F Burgess Method and apparatus for sterilizing.
JPS5541210B2 (es) * 1974-01-29 1980-10-22
US4316787A (en) 1979-08-06 1982-02-23 Themy Constantinos D High voltage electrolytic cell
US4236992A (en) 1979-08-06 1980-12-02 Themy Constantinos D High voltage electrolytic cell
US4671955A (en) * 1986-03-31 1987-06-09 Victor Palinczar Waterproof sunscreen compositions
US4983779A (en) * 1986-07-17 1991-01-08 The Board Of Governors Of Wayne State University Process for the preparation of vinyl ethers
JPS6456188A (en) 1987-03-11 1989-03-03 Tatsuo Okazaki Electrolyzer for water
GB8807752D0 (en) 1988-03-31 1988-05-05 Unilever Plc Bleaching composition
US4956184A (en) 1988-05-06 1990-09-11 Alcide Corporation Topical treatment of genital herpes lesions
US5334383A (en) 1990-05-23 1994-08-02 Medical Discoveries, Inc. Electrically hydrolyzed salines as in vivo microbicides for treatment of cardiomyopathy and multiple sclerosis
US5622848A (en) 1990-05-23 1997-04-22 Medical Discoveries, Inc. Electrically hydrolyzed salines as microbiocides for in vitro treatment of contaminated fluids containing blood
EP0627474B1 (en) * 1993-05-13 2000-10-25 American Cyanamid Company Aqueous silicone coating compositions
US5507932A (en) 1994-08-26 1996-04-16 Schlumberger Technology Corporation Apparatus for electrolyzing fluids
US6117285A (en) 1994-08-26 2000-09-12 Medical Discoveries, Inc. System for carrying out sterilization of equipment
FR2740777B1 (fr) * 1995-11-02 1998-01-02 Hutchinson Films d'elastomere contenant au moins une substance chimique active, leur procede de preparation et leurs applications
SG60166A1 (en) * 1996-12-09 1999-02-22 Becton Dickinson Co Waterborne lubricant for teflon products
WO1999034773A1 (en) 1998-01-06 1999-07-15 The Procter & Gamble Company Antimicrobial peroxy acid oral care compositions and methods
US6114398A (en) 1998-03-03 2000-09-05 Ratcliff; Perry A. Personal lubricant to prevent and stop itching
GB2355190B (en) 1999-08-23 2004-07-28 Sterilox Medical Improvements in or relating to sterilising preparations
US6333054B1 (en) 1999-10-21 2001-12-25 Amuchina S.P.A. Topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties
US6589568B2 (en) 2001-02-16 2003-07-08 Nurad, Inc. Therapeutic body lotion containing alkali metal hypohalite
SE0103766D0 (sv) 2001-11-09 2001-11-09 Astrazeneca Ab Novel assay
US10117812B2 (en) * 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20050089537A1 (en) 2003-10-27 2005-04-28 Birnholz Jason C. Personal lubricant with silicone polymers
GB0328124D0 (en) 2003-12-04 2004-01-07 Daly James Membrane electrolyser with a two part end design
US20050196462A1 (en) 2003-12-30 2005-09-08 Oculus Innovative Sciences, Inc. Topical formulation containing oxidative reductive potential water solution and method for using same
US20080003171A1 (en) 2004-04-20 2008-01-03 Smith William L Microbial Control Using Hypochlorous Acid Vapor
US8062501B2 (en) 2004-10-08 2011-11-22 Ube Industries, Ltd. Neutral electrolytic water, neutral electrolytic water production method and device thereof
EP1829449A4 (en) 2004-11-24 2008-10-08 Maruishi Pharma STERILIZATION COMPOSITION BASED ON LOW-CHLORINOUS ACID
GB0504547D0 (en) 2005-03-04 2005-04-13 Delsol Products Ltd Personal lubricant
AU2006226750B2 (en) 2005-03-23 2012-07-19 Oculus Innovative Sciences, Inc. Method of treating skin ulcers using oxidative reductive potential water solution
US20060241002A1 (en) 2005-04-26 2006-10-26 Rogozinski Wallace J Sodium hypochlorite gel composition
US8083586B2 (en) 2005-06-22 2011-12-27 Nokia Corporation System and method for providing interoperability of independently-operable electronic games
US20070172412A1 (en) 2006-01-26 2007-07-26 Linda Hratko Thickened fluid composition comprising chlorine dioxide
US20090169646A1 (en) 2006-02-22 2009-07-02 Puricore, Inc. Methods of treating cystic fibrosis
US8673297B2 (en) 2006-02-28 2014-03-18 Basf Corporation Chlorine dioxide based cleaner/sanitizer
US20070281008A1 (en) 2006-06-05 2007-12-06 Lin Shun Y Personal lubricant compositions and kits for providing personal lubrication
EP1886664A1 (en) 2006-08-08 2008-02-13 José Sidnei Pereira N-chloroamines containing compositions
US8877257B2 (en) 2007-01-16 2014-11-04 Puricore, Inc. Methods and compositions for treating conditions associated with infection and/or inflammation
CN101932330B (zh) 2007-03-13 2015-01-14 奥古露丝创新科学公司 包括一氧化二氯的抗微生物溶液及其制备和使用方法
GB0713799D0 (en) 2007-07-17 2007-08-22 Byotrol Llc Anti-microbial compositions
US20090068122A1 (en) 2007-09-06 2009-03-12 Shira Pilch Dentifrice Compositions for Treating Xerostomia
US8770201B2 (en) * 2007-10-26 2014-07-08 Glycobiosciences Inc. Condom with multifunctional coating
US20090148342A1 (en) 2007-10-29 2009-06-11 Bromberg Steven E Hypochlorite Technology
US9446072B2 (en) 2007-10-30 2016-09-20 Reoxcyn Discoveries Group, Inc. Methods of ameliorating oxidative stress by increasing the efficiency of GPX and SOD activity
US20150093451A1 (en) 2007-10-30 2015-04-02 Reoxcyn Discoveries Group, Inc. Method of increasing energy expenditure
US20140044800A1 (en) 2007-10-30 2014-02-13 Daniel Robinson Stable Reactive Oxygen Composition
US8945630B2 (en) 2008-04-11 2015-02-03 Aquilabs S.A. Method of producing and applications of composition of hypochlorous acid
WO2010004699A1 (ja) 2008-07-09 2010-01-14 野口歯科医学研究所株式会社 口臭抑制剤及びその生成方法
WO2010009131A2 (en) 2008-07-15 2010-01-21 Basf Catalysts Llc Tooth polishing compositions and methods of tooth polishing without mechanical abrasion
US20100078331A1 (en) 2008-10-01 2010-04-01 Scherson Daniel A ELECTROLYTIC DEVICE FOR GENERATION OF pH-CONTROLLED HYPOHALOUS ACID AQUEOUS SOLUTIONS FOR DISINFECTANT APPLICATIONS
US20100012132A1 (en) 2008-11-12 2010-01-21 Chemsil Silicones, Inc. Clear, washable lubricant compositions, and methods of making same
BRPI0922164A2 (pt) 2008-12-17 2019-09-24 Tennant Co aparelho e método para aplicar carga elétrica através de um líquido
WO2010080836A2 (en) 2009-01-06 2010-07-15 C3 Jian, Inc. Antibacterial and antifungal peptides
CA2756695A1 (en) 2009-03-23 2010-09-30 Kross-Link Laboratories Method for suppressing or preventing fibrous adhesion formation using a multicomponent aqueous oxychlorine composition prepared on-site
WO2011014809A1 (en) 2009-07-30 2011-02-03 Oculus Innovative Sciences, Inc. Hydrogel formulation comprising oxidative reductive potential water
US20110052506A1 (en) 2009-08-31 2011-03-03 Collegium Pharmaceutical, Inc. Stable Aerosol Topical Foams Comprising a Hypochlorite Salt
US20110065798A1 (en) * 2009-09-17 2011-03-17 Becton, Dickinson And Company Anti-infective lubricant for medical devices and methods for preparing the same
US20120046556A1 (en) * 2010-04-09 2012-02-23 Block Robert M Methods and Kits for Preventing the Spread of Sexually Transmitted Microorganisms
EP2601245A1 (en) 2010-08-05 2013-06-12 Biofilm IP, LLC Cyclosiloxane-substituted polysiloxane compounds, compositions containing the compounds and methods of use thereof
US20120148516A1 (en) 2010-12-10 2012-06-14 Precision Dermatology, Inc. Tandem Hypochlorite-Barrier Repair Therapy for the Treatment of Eczema
CN102167997B (zh) 2011-03-11 2013-06-12 刘小清 一种不需防腐剂的天然消毒洗涤组合物
ES2741480T3 (es) 2011-03-18 2020-02-11 Urgo Us Inc Soluciones estabilizadas de ácido hipohaloso
US20130164228A1 (en) 2011-12-21 2013-06-27 Colgate-Palmolive Company Compositions comprising gallates and gallamides
CN104245781B (zh) 2012-02-20 2018-09-21 巴斯夫欧洲公司 用聚合物提高生物杀伤剂的抗微生物活性
WO2014055627A1 (en) 2012-10-04 2014-04-10 Church & Dwight Co., Inc. Water-based personal lubricants with a silicone component
EP2903627B1 (en) 2012-10-04 2018-11-28 Church & Dwight Co., Inc. Non-irritating lubricant compositions with active sensorial agents
EP3016664A1 (en) 2013-07-01 2016-05-11 Puricore Inc. Antimicrobial compositions comprising hypochlorous acid and silver
JP2015016408A (ja) 2013-07-10 2015-01-29 モレックス インコーポレイテドＭｏｌｅｘ Ｉｎｃｏｒｐｏｒａｔｅｄ 酸性電解水およびその製造方法、ならびに該酸性電解水を含む洗浄剤および殺菌剤
US20150099010A1 (en) 2013-10-07 2015-04-09 Reoxcyn Discoveries Group, Inc Redox signaling gel formulation
WO2015061753A1 (en) 2013-10-24 2015-04-30 Reoxcyn Discoveries Group, Inc. Redox signaling gel formulation
US20150125543A1 (en) 2013-11-07 2015-05-07 Simple Science Limited Gel disinfecting composition
CN104922055A (zh) * 2014-03-19 2015-09-23 张益寿 用于润滑保湿消毒灭菌的半流体组成物及其使用方法
CN104476966A (zh) * 2014-11-12 2015-04-01 颍上县陈家工艺家具有限公司 基于木质家具镶嵌贝壳拼花的工艺
CA2970804C (en) 2014-12-16 2023-01-31 Realm Therapeutics, Inc. Hypochlorous acid formulations and methods for treating skin conditions
WO2017127452A1 (en) 2016-01-19 2017-07-27 Reoxcyn Discoveries Group, Inc. Hypochlorite formulations for wound healing
US9474768B1 (en) 2016-05-18 2016-10-25 Reoxcyn Discoveries Group, Inc. Lubricant formulations

Also Published As

Publication number Publication date
RU2017104902A3 (es) 2020-03-24
US10471003B2 (en) 2019-11-12
JP2017206668A (ja) 2017-11-24
BR102017003973A2 (pt) 2017-12-05
US9474768B1 (en) 2016-10-25
US11083689B2 (en) 2021-08-10
US20200237655A1 (en) 2020-07-30
CN107397757A8 (zh) 2018-06-19
RU2747029C2 (ru) 2021-04-23
TW201919660A (zh) 2019-06-01
NZ725569A (en) 2018-02-23
RU2017104902A (ru) 2018-08-15
US9833406B1 (en) 2017-12-05
US20180325809A1 (en) 2018-11-15
JP6464406B2 (ja) 2019-02-06
TWI674099B (zh) 2019-10-11
NZ738113A (en) 2018-07-27
TW201740956A (zh) 2017-12-01
CN107397757A (zh) 2017-11-28
KR20170130275A (ko) 2017-11-28
US20170333343A1 (en) 2017-11-23
MX2016013744A (es) 2017-11-17
KR102649938B1 (ko) 2024-03-22
TWI674098B (zh) 2019-10-11
JP2019059950A (ja) 2019-04-18
ZA201607310B (en) 2020-08-26
JP6821639B2 (ja) 2021-01-27
WO2017200565A1 (en) 2017-11-23

Similar Documents

Publication Publication Date Title
MX369169B (es) Formulaciones de lubricante.
MX2019003735A (es) Formulaciones diluibles de cannabinoides y procesos para su preparacion.
PH12020550840A1 (en) Spray-dried lacto-n-fucopentaose
SG10201805246XA (en) Approximated parameter adaptation
MX2022016566A (es) Composiciones que comprenden una caseina y metodos para producir las mismas.
MY191581A (en) Anti-pd-1 antibodies
MX2019001313A (es) Composiciones farmaceuticas.
MX2018016038A (es) Compuestos y metodos para modular la funcion del acido ribonucleico (arn).
PH12019501872A1 (en) Anti-tryptase antibodies, compositions thereof, and uses thereof
MX2022000053A (es) Moduladores de interaccion de sestrina-gator2 y sus usos.
MX2019002057A (es) Formas solidas de mesilato de cenicriviroc y procesos para elaborar formas sólidas de mesilato de cenicriviroc.
MX2020013630A (es) Analogos de rapamicina y usos de los mismos.
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
MX2018000395A (es) Proteinas y composiciones inmunizantes que contienen proteinas de klebsiella y metodos de uso.
MX2018000515A (es) Compuestos fluorados de cbd, composiciones y usos de los mismos.
MX2019005855A (es) Formulaciones que se pueden pulverizar.
PH12018502233A1 (en) ErbB INHIBITORS AND USES THEREOF
EP4234552A3 (en) 3-phosphoglycerate dehydrogenase inhibitors and uses thereof
WO2018083465A3 (en) Composition useful to simulate tobacco aroma
WO2020123816A3 (en) Anellosomes and methods of use
MX2019007041A (es) Metodos y composiciones para tratar la enfermedad de parkinson.
WO2017161344A8 (en) Compositions and methods for treating parasitic diseases
MX2020012990A (es) Formulaciones de tegavivint y compuestos relacionados.
MA39877A (fr) Formes solides d'un composé pharmaceutiquement actif
PH12017501869A1 (en) (s)-2'-vinyl-abscisic acid derivatives

Legal Events

Date Code Title Description
GB Transfer or rights

Owner name: REOXCYN, LLC.

HC Change of company name or juridical status

Owner name: REOXCYN, LLC.

FG Grant or registration